Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 8/20 | 0.55 |
| ▸ | ACE | P12821 | 7/20 | 0.55 |
| ▸ | CPA1 | P15085 | 7/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 7/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP7 | P09237 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | MMP12 | P39900 | 1/20 | 0.48 |
| ▸ | MMP13 | P45452 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10752313 | 0.93 | ALDH1A1 (0.50) | MMEACECPA1ACE2 | |
| SCHEMBL10752317 | 0.93 | ALDH1A1 (0.50) | MMEACECPA1ACE2 | |
| SCHEMBL30375020 | 0.89 | SLC15A1 (0.58) | MMEACECPA1ACE2 | |
| SCHEMBL12202988 | 0.88 | MME (0.56) | MMEACECPA1ACE2MMP2 | |
| SCHEMBL135150 | 0.88 | MME (0.56) | MMEACECPA1ACE2MMP2 | |
| SCHEMBL11122650 | 0.88 | MME (0.56) | MMEACECPA1ACE2MMP2 | |
| SCHEMBL7257544 | 0.88 | MME (0.50) | MMEACECPA1ACE2L3MBTL1 | |
| Hydrochloric Acid SCHEMBL10765384 | 0.87 | MME (0.55) | MMEACECPA1ACE2MMP2 | |
| SCHEMBL7101568 | 0.84 | MMP8 (0.51) | MMP2 | |
| SCHEMBL13963726 | 0.83 | MME (0.64) | MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389240-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-8361748-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20120301918-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2012-11-29 | — | — | US | disclosed |
| US-20120295304-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2012-11-22 | — | — | US | disclosed |
| EP-2180060-B1 | Method for produding alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-08-29 | — | — | EP | disclosed |
| EP-2180061-B1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-08-29 | — | — | EP | disclosed |
| US-8247193-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2012-08-21 | — | — | US | disclosed |
| EP-2180059-B1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2157188-B1 | Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-05-02 | — | — | EP | disclosed |
| EP-2166109-B1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | AJINOMOTO KK (JP) | 2012-02-22 | — | — | EP | disclosed |
| EP-2180061-A1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | Ajinomoto Co., Inc. (JP) | 2010-04-28 | — | — | EP | disclosed |
| EP-2166109-A1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | Ajinomoto Co., Inc. (JP) | 2010-03-24 | — | — | EP | disclosed |
| EP-2157188-A1 | Method for producing alpha-L-Aspartyl-L-phenylalanine-Beta-ester and method for producing alpha-L-aspartyl-L-phenylalanine-alpha-methyl ester | Ajinomoto Co., Inc. (JP) | 2010-02-24 | — | — | EP | disclosed |
| EP-1587941-B1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO KK (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090191600-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2009-07-30 | — | — | US | disclosed |
| US-7361458-B2 | Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester | AJINOMOTO CO., INC. (JP) | 2008-04-22 | — | — | US | disclosed |
| EP-1587941-A4 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | AJINOMOTO KK (JP) | 2006-06-21 | — | — | EP | disclosed |
| EP-1587941-A1 | METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-BETA-ESTER AND METHOD FOR PRODUCING ALPHA-L-ASPARTYL-L-PHENYLALANINE-ALPHA-METHYL ESTER | Ajinomoto Co., Inc. (JP) | 2005-10-26 | — | — | EP | disclosed |
| US-20050124035-A1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther | AJINOMOTO CO., INC. (JP) | 2005-06-09 | — | — | US | disclosed |
| WO-2004065610-A1 | METHOD FOR PRODUCING α- L-ASPARTYL-L-PHENYLALANINE-β-ESTER AND METHOD FOR PRODUCING α-L-ASPARTYL-L-PHENYLALANINE-α-METHYL ESTER | AJINOMOTO CO., INC. (JP) | 2004-08-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124035-A1 | Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther | DNPEP, ASPH, PEPD | MME 49/4885ACE 74/4885CPA1 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.